Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about Ocugen Inc/

Recent news which mentions Ocugen Inc/

Lab Notes: Imvax advances brain cancer treatment; Wistar identifies promising compound for HIV patients
Tickers INNO
Tags Inno Insurance GlaxoSmithKline PLC
From Business Journals
Lab Notes: Fox Chase Cancer Center researcher gets $1M grant; NRx raises funds
Tickers INNO
Tags Carisma Therapeutics Sanjay S/ Subramanian Biotech
From Business Journals
Lab Notes: Wedgewood Pharmacy acquires Colorado lab; Aprea Therapeutics raises $5.5M
Tickers INNO
Tags Chris Mirabelli John Karanicolas Insurance
From Business Journals
Lab Notes: Drexel and Bancroft team up to advance autism research; AmerisourceBergen forms new partnership
Tickers INNO
Tags Pharmaceuticals Quan A/ Vu Medical Devices
From Business Journals
Lab Notes: Neuronetics resolves lawsuit; Harmony CEO departs; Ocugen issues results of Covaxin study
Tickers INNO
Tags Health Care Antony Koblish Harmony Biosciences Holdings Inc/
From Business Journals
Lab Notes: Chimeron Bio names new CEO; Amicus Therapeutics gets positive opinion for rare disease therapy
Tickers INNO
Tags Biotech Timothy Henkel Jolly Mazumdar
From Business Journals
Lab Notes: Cabaletta signs licensing deal for up to $162M; merger unites life sciences tech providers
Tickers INNO
Tags Michael Rosenzweig Insurance Inno
From Business Journals
Lab Notes: Integral Molecular has first submission for new FDA pilot program; Jefferson ALS program expanding
Tickers INNO
Tags Galera Therapeutics Inc/ Ocugen Inc/ Robert J/ Hopkins
From Business Journals
Ocugen's efforts to bring Covid-19 vaccine Covaxin to U.S. boosted by positive study results in children
Tags Biotech Insurance Pharmaceuticals
From Business Journals
Lab Notes: Endo gets U.S. rights to potential knee pain drug; Optinose stock climbs after positive study results
Tickers INNO
Tags Ramy Mahmoud Biotech Roundup
From Business Journals
Ocugen gets rights to Mexico in expanded Covaxin deal with Bharat Biotech
Tags Pharmaceuticals Shankar Musunuri Biotech
From Business Journals
Ocugen's study of Covid-19 vaccine Covaxin put on hold in wake of WHO inspection of Bharat
Tags Ocugen Inc/ Health Care Coronavirus
From Business Journals
Lab Notes: Venatorx closes Series C financing; Ocugen takes 'critical' step in clinical trial
Tickers INNO
Tags Biocoat John Lee Medical Devices
From Business Journals
Lab Notes: Chimeron's Covid-19 vaccine candidate shows promise; Lannett gets 2nd NYSE delisting notice
Tickers INNO
Tags Lannett Co Inc Pharmaceuticals Recro Pharma Inc/
From Business Journals
Ocugen's stock plummets after FDA rejects emergency use bid for Covid vaccine
Tags Ocugen Inc/ Health Care Coronavirus
From Business Journals
Ocugen expects $53.5M from stock sale amid efforts to bring Covaxin to the U.S.
Tags Pharmaceuticals Insurance Biotech
From Business Journals
Ocugen signs letter of intent to buy Canadian pharmaceutical manufacturing plant
Tags Health Care Ocugen Inc/ Alek Krstajic
From Business Journals
Lab Notes: Strata Skin Sciences makes acquisition; Cabaletta Bio promotes 2 executives
Tickers INNO
Tags Steven Nichtberger Madrigal Pharmaceuticals Inc/ Gwendolyn Binder
From Business Journals
Lab Notes: Trevena advances new pain drug; Ocugen receives good news from FDA
Tickers INNO
Tags Roundup Biotech Harmony Biosciences Holdings Inc/
From Business Journals
FDA places a hold on Ocugen's plan for U.S. trials of the Covid-19 vaccine Covaxin
Tags Biotech Insurance Pharmaceuticals
From Business Journals
Ocugen applies for emergency FDA authorization for use of its Covid-19 vaccine in children
Tags Insurance Biotech Shankar Musunuri
From Business Journals
Lab Notes: Trice gets FDA approval for device; Ocugen files to begin Covid-19 vaccine trial
Tickers INNO
Tags Trice Medical, Inc/ Windtree Therapeutics Inc/ Craig Fraser
From Business Journals
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.